Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion

Inhibition of proteases shows therapeutic potential. Our previous studies demonstrated the cardioprotection by the Secretory Leukocyte Protease Inhibitor (SLPI) against myocardial ischaemia/reperfusion (I/R) injury. However, it is unclear whether the cardioprotective effect of SLPI seen in our previ...

Full description

Bibliographic Details
Main Authors: Podsawee Mongkolpathumrat, Anusak Kijtawornrat, Eukote Suwan, Sasimanas Unajak, Aussara Panya, Tonapha Pusadee, Sarawut Kumphune
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
myocardial ischaemia/reperfusion injury
SLPI
cardioprotection
protease activity
anti-protease deficient
Online Access:https://www.mdpi.com/2227-9059/10/5/988

Internet

https://www.mdpi.com/2227-9059/10/5/988

Similar Items